Deep Tech VC - Co-Founder @SpecialeInvest. Previously: entrepreneur, product guy, developer. Enjoy Start-ups, Sports, Poker.

Bengaluru
Joined August 2008
"This isn't where the story ends. This is where it gets interesting." ⚡✈️✈️
"The day you stop asking whether it's possible and start asking how... that's the day the work actually begins." 3 aircrafts. 1 hangar. Zero playbooks. No one in India had walked this road before us. Just a problem worth solving, a team willing to do the work, and the quiet decision to keep going. • ATVA (2021): Small, unassuming, but our first real proof that this wasn't just math on paper. • e50 (2023): Scaling up the physics to 50kg and finding our rhythm in the sky. • e200X (2026): 7 years of R&D, 10,000+ km of test flights, and a 2.2-ton full-scale electric aircraft built by hand. PT-01 is the answer to every doubt along the way. We could. We did. This isn't where the story ends. This is where it gets interesting. ⚡
2
330
Replying to @iamjakestream
@iamjakestream of @btv_vc wrote a salient synopsis on the venture market. Blog in the replies I agree with everything in it, especially with the theme that consensus investing is creating a very real risk bubble (financial). I see it on both sides of the table, LPs and GPs. Increasingly, Jake is right that career risk is being optimized over financial risk and the pursuit of asymmetric, right-tail outcomes. It's safer to be wrong with everyone else than to be right alone. That's a dangerous dynamic for an asset class built on finding outliers. A few takeaways I really agree with. 1. Consensus has made its way into seed. Increasingly, the same founder pedigrees, sectors, and narratives attract capital, particularly from multi-stage firms. Seed investors are taking note of what is likely to get funded by a Tier-1 investors at large markups, and the the result is passing on non-obvious and focusing on what likely gets a strong follow on. This of course means higher prices, as consensus deals (AI in particular) 30-50%+ higher in price. I worry a lot of this ends badly. Too much capital, too early, can artificially accelerate companies before they've figured out what actually works. Instead of carefully navigating toward product-market fit, they're pushed into a trajectory that can end with hitting a wall. 2. We're creating a funding gap for durable businesses. I've talked about the 3/3/3/2/2 companies before. Businesses that compound steadily, build real value, and have strong underlying economics. Many are being orphaned by the venture ecosystem. They're not growing fast enough for multi-stage VC, but they're too early for traditional PE or larger growth investors. And when growth capital is available, the valuation expectations don't always make sense. These companies need a capital source. Not every great outcome needs to be a $50B company, especially for a smaller niche firm. 3. Founders are feeling the pressure to manufacture consensus. When the market rewards certain growth narratives above everything else, behavior changes. We're seeing increasingly creative interpretations of metrics. Calling something $3.65M in ARR because you generated $10K in revenue on a single day and multiplied it by 365 is not ARR. At best, it's misleading. At worst, it crosses into deliberate misrepresentation. I worry we're seeing more of the latter as founders feel compelled to demonstrate hypergrowth at all costs. 4. This too shall pass. I suspect the next 12 months will bring a reckoning. Capital will become more discerning, growth claims will face more scrutiny, and we'll find out who's been swimming naked. That said, I believe this is one of the best times in history to build a technology company and invest in innovation. The amount of value that will be created over the next 10–15 years is going to dwarf anything we've seen before. But the current dynamics aren't sustainable for much longer.
8
6
40
3,744
Heard from VC LPs this week. It was our AGM, so I had a ton of convos. Theme is liquidity and differentiation. Some quotes 👇🏻 - “we see a huge difference btw the posture of the GPs who do public + private and those that just do VC/Growth. They are living in different realities.” - “every GP is raising again faster than we thought, either because they just blew through the money, or because they want a war chest for when the market trips over itself” - “Across the top GPs, everyone is in market. TVPIs look amazing - differentiation is DPI, concentration and portfolio mgt” - “We really need the PE guys to start selling some stuff!!” - “If Anthropic IPO goes great, we are worried it sets the bar too high for everyone else. And if it doesn’t go great, then the bar is even higher…”
20
13
3
192
44,008
BREAKING: Scientists have used a powerful new form of CRISPR called prime editing directly inside the human body for the first time. They aim to rewrite faulty DNA responsible for Wilson disease that can cause severe liver and brain damage. A major milestone in gene editing.
29
69
14
782
62,200
Ashlee - I have been a US-India cross-border VC for a decade and a half now. And I totally get the sentiment around the journey of Ather and many such hardware companies that started in the 2010-2020 generation. They truly struggled to raise early-stage capital in India, given VC was concentrating into eCommerce and Fintech in that decade. Even in those years, the likes of Speciale Invest, YourNest, GrowX, Endiya, VentureEast, Blume, as well as Indian arms of global VCs like Accel, did provide early-stage capital to hardware companies, but the quantum was relatively small, hard to access, and at very low valuations (founders from that generation saw insane dilution levels very early). This has dramatically changed now. India has an active base of angels, micro-VCs, homegrown VCs, global VCs, and strategics/ corporate Family Offices who are willing to bet at the pre-seed & seed stage in deeptech/ hardware. Further, the Govt. is now diverting sovereign money to these managers for early-stage deeptech investing, committing ~$12B over the next 6 years via the RDI scheme. Top-tier tech schools like the IITs, IISc, BITS, etc. now have vibrant incubation programs, many of which have also been allocated RDI LP dollars by the govt. with the objective that early-stage tech derisking in deeptech companies can be funded by them. Also, similar to the US for many decades now, India now has many examples of professors and researchers stepping out to start venture-backed companies that leverage their academic work (eg., Prof Satya of IIT Madras with ePlane and Prof Arin of IIT Bombay with Inspecity). However, I do agree that the Indian venture ecosystem at large needs to: (1) Show more courage & patience at the pre-seed stage. (2) Deliver a better experience for founders, both during the investment process as well as in portfolio value creation. (3) Unlock domestic growth-stage capital for deeptech, as the funnel really dries up at Series B and beyond. But taking a step back, the Indian deeptech venture ecosystem has come a long way since 2011 (which is when I entered venture in India), has shown continued progress on every front, and I expect this to continue and, in fact, become faster over the next decade, with geopolitical realignment + India's macroeconomic growth & scale providing tailwinds. PS: As an aside, I run a Solo GP fund called Operators Studio @opsstudiovc here in SF, where, in addition to backing Silicon Valley startups leveraging India, I have also actively invested in India-based deeptech startups that have the ambition and capability to go global. Like you, I am bullish on India deeptech as a decadal venture theme well into the 2030s. Below is a quick snapshot of my India-based deeptech portfolio (all manufacturing locally). I have been a first check Superangel investor in almost every case: 1) Spacetech - @AuleSpace, @AstrophelHQ, @Cosmochute 2) Aerospace - Aspera (from the Hoskote gang), @ParsecAerospace 3) Precision Engineering & Manufacturing - @NaxatraLabs, @Adiabatic_IN 4) Defense-tech - @SharangShakti, @HyprixAviation 5) Materials - CarbonStrong, Planet Material Labs 6) Consumer Hardware - @cradlewise, @BreethrHQ 7) Robotics - @osmosbot 8) Mobility - @Blinqmobility ...and many more in the pipeline for this Fund.
Why are Indian VCs so afraid to take risk and make money? Someone should go to India and take risk and make money. Our story - corememory.com/p/a-new-india…
10
18
4
192
18,565
JUST IN: Srinath Ravichandran, Co-founder & CEO of Agnikul Cosmos, will be joining us tonight on India Money Live at 9 PM He will be decoding: 🛰️ The future of India’s private space sector 🚀 Building world class deep tech from India 💡 Opportunities in rockets, satellites and space-tech Join us live on X & YouTube for an insightful Q&A session @AgnikulCosmos
1
3
15
1,057
Arjun retweeted
Another C-CAMP startup receives #RDI funding! 🚀 C-CAMP #AIinDrugDiscovery startup #Peptris has signed an agreement for funding support of 86Cr INR (9M+ USD) with @tdbgoi, at a total project cost of 172 Crs INR (18.22M+ USD). This committed funding of ₹86 Crs will accelerate Peptris' AI-driven drug discovery and development pipeline, from computational discovery to therapeutic candidates with clinical potential. Read about this news: 🔗pib.gov.in/PressReleasePage.… Peptris is working on 4 AI-discovered drug candidates in #oncology #neuromusculardisorders #DMD #alopecia #neuropathy towards clinical development. Currently in TRL 4, Peptris is aiming to complete pre-clinical and IND studies of all four molecules, translating them to TRL 6 with the funding. Peptris has already demonstrated early success with their #DucheneeMuscularDystrophy #RareDiseases drug receiving @US_FDA Orphan Drug Designation, the first AI-discovered molecule from India to achieve this milestone. Congratulations! Know more about their innovation: medium.com/@c-camp/peptris-t… @Taslimarif_IND @DrJitendraSingh @IndiaDST @PrinSciAdvOff @PrinSciAdvGoI @DBTIndia @BIRAC_2012 @AIMtoInnovate @IndiaDsir @DeptHealthRes @NITIAayog @startupindia @GoI_MeitY @meitystartuphub @ITBTGoK @Startup_Kar @Ktech_biotech @ICMRDELHI @CSIRIndia @wadhwanif
3
2
8
774
The #RDI momentum continues! More @CCAMP_India startups are securing massive fundraises!🚀 And this time, it's C-CAMP’s #AIinDrugDiscovery startup Peptris. Peptris has signed an agreement for funding support of 86Cr INR (9M+ USD) with @tdbgoi, at a total project cost of 172 Crs INR (18.22M+ USD)! Peptris' platform designs new drug molecules for cancers and rare diseases by leveraging AI, cutting down the slow and costly lab trial-and-error approach behind most drug failures. They are already working on 4 AI-discovered drug candidates in #oncology #neuromusculardisorders #DMD #alopecia #neuropathy towards clinical development. More info below👇 @PMOIndia @DrJitendraSingh @AshwiniVaishnaw @JPNadda @PrinSciAdvOff @PrinSciAdvGoI @IndiaDST @DBTIndia @BIRAC_2012 @NITIAayog @AIMtoInnovate @meitystartuphub @GoI_MeitY @DPIITGoI @startupindia @PriyankKharge @ITBTGoK @Startup_Kar @shivkuma_k @waghmare16 @kris_sg @kiranshaw @kvijayraghavan @RenuSwarup
Another C-CAMP startup receives #RDI funding! 🚀 C-CAMP #AIinDrugDiscovery startup #Peptris has signed an agreement for funding support of 86Cr INR (9M+ USD) with @tdbgoi, at a total project cost of 172 Crs INR (18.22M+ USD). This committed funding of ₹86 Crs will accelerate Peptris' AI-driven drug discovery and development pipeline, from computational discovery to therapeutic candidates with clinical potential. Read about this news: 🔗pib.gov.in/PressReleasePage.… Peptris is working on 4 AI-discovered drug candidates in #oncology #neuromusculardisorders #DMD #alopecia #neuropathy towards clinical development. Currently in TRL 4, Peptris is aiming to complete pre-clinical and IND studies of all four molecules, translating them to TRL 6 with the funding. Peptris has already demonstrated early success with their #DucheneeMuscularDystrophy #RareDiseases drug receiving @US_FDA Orphan Drug Designation, the first AI-discovered molecule from India to achieve this milestone. Congratulations! Know more about their innovation: medium.com/@c-camp/peptris-t… @Taslimarif_IND @DrJitendraSingh @IndiaDST @PrinSciAdvOff @PrinSciAdvGoI @DBTIndia @BIRAC_2012 @AIMtoInnovate @IndiaDsir @DeptHealthRes @NITIAayog @startupindia @GoI_MeitY @meitystartuphub @ITBTGoK @Startup_Kar @Ktech_biotech @ICMRDELHI @CSIRIndia @wadhwanif
3
13
373
We’re hiring 🛰️ Build the world’s only OptoSAR satellites with us in Bangalore. Opto-Mechanical Lead GNC Lead Sr. Spacecraft Software Engineer Sr. Spacecraft Structure Engineer Composite Structure Engineer Sr. Hardware Design Engineer Links below👇 #SpaceTech #Hiring #NewSpace
3
2
14
466
Growth investors today are either dragging right, exponential surfing, or supply-side investing. Each requires a completely different investing style and craft, and it's important to know which applies. Dragging right is traditional growth investing. You take a business with an established, predictable, repeatable go-to-market motion based on either consumer acquisition or enterprise sales reps/quotas, and the investors' job is to figure out whether it can scale. "Okay, this company has twenty reps- can it hire another forty? Will the LTV:CAC hold?" Greatness in evaluating this came down to understanding TAMs/market segments, the breadth of product-market fit, competitive dynamics (often gentle), and how to analyze spreadsheet data/customer calls for signs of potential weaknesses. This was effectively all SaaS investors had to do for the last ten years, and it was glorious. The entire growth investing industry as we know it today was built around this model of funding predictable g-t-m machines with a fairly narrow range of outcomes- and the skillsets that made someone great at it were all about g-t-m logic, TAM analysis, customer work, etc. Exponential surfing has been the dominant growth investing strategy of the last two years. Consider Anthropic twelve months ago- if you had complete access to the traditional customer data/analytics and spoke to all of the customers, you would find nothing to predict the massive acceleration it saw from December 2025-April 2026. It is literally a completely different game, and most (not all) of the AI companies with material revenue are playing some version of it- not only is their revenue growth hard to predict for investors, it is largely out of their hands as well, dependent on whether the latest models have emergent, high-value, fast-propagating use cases. Greatness here is still emerging, but as far as I can tell the two ways to have been early to the Anthropic inflection were to be using the products oneself (so you can feel the step-function in capabilities in real time) or obsessively tracking the coincident data (Openrouter, credit card panels, etc.) for signs of sustained acceleration. A strong silicon Valley practitioner whisper-network is perhaps the third way. What is definitely NOT great is using SaaS terminology metrics (Y/y growth, gross retention, LTV:CAC, ARR, etc.) to characterize this wave of companies. Yes, many of them are "growing faster than SaaS ever did," but also the base rate of them stopping on a dime (or even shrinking) is much higher. It's just a fundamentally different business model, arguably with no clear precedent. Supply-side investing has risen to prominence in the last 12-18 months. This involves investing in businesses that are pre-product, where the economic value of the product is crystal clear... if it can get built/produced at scale. Neolabs, semis startups, certain very ambitious agent starts, defense tech, robotics startups, etc. all fit this bucket. Greatness here is about understanding technical challenges and unlocks in granular detail, studying talent flows, gauging which teams have the right combination of research and commercialization chops, etc. The rewards for getting it right are enormous (see: pre-revenue Anthropic investors), but the diligence is, again, completely different. What is NOT great is talking to dozens of potential customers who all breathlessly assure you that they would love to buy chips 10x more efficient than Vera Rubins at half the price. That is about as useful as reading LOIs from those same customers to buy them by the billions- aka not useful at all. Referring to those LOIs as "CARR" is, well, fantastical. In supply-side growth investing, the demand side is obvious by definition. Again- there are great investors who will find ways to make money in all of these styles, but it has never been more important to understand which version of investing you're doing and to apply yourself to being excellent at it in a way that fits the game you've chosen to play, not to apply the techniques of yesteryear.
12
8
2
135
14,328
This reasoning is exactly right. I think the S&P or Nasdaq are fair benchmarks, and there should also be a premium-on-top of those given venture's illiquidity. The percentile venture fund that beats those benchmarks is creeping higher and higher. Much worse, venture firms are increasingly, implicitly targeting returns that are lower. At some point, they will achieve the returns they're implicitly targeting AND LPs will realize the appropriate hurdle. At that point I think the venture capital cycle will turn aggressively
What's the appropriate hurdle for venture? Over the last 10 years: S&P was ~4.05x / 15.1% IRR QQQ was ~6.39x / 20.4% IRR FAANG was ~8.33x / 23.6% IRR S&P would be a 90th+ percentile fund and QQQ/FAANG would both be 95th+ percentile. And fully liquid.
7
11
3
139
42,529
Arjun retweeted
This is not new, unfortunately. I remember meeting a hedge fund neighbor in SF who was commenting about another neighbor (who was an older prominent VC). He would comment that the VC was always so enthusiastic about every one of his companies that was about to IPO. The hedge fund guy would then put it on his list of ideas to short and claimed he did very well. This was 25+ years ago when I used to live in SF.
1
1
45
9,206
Given the current concentration of capital into venture ‘megafunds,’ we wanted our next LP guest on Origins to speak to how they are investing into this market and what their return expectations are. Welcome @Curiousjorge65, who manages @CarnegieMellon's $4B endowment NEW Origins! 🧵
10
3
2
42
4,848
About pre-seed/seed Real Madrid can buy almost any established star in the world. That doesn’t mean they are automatically the best academy for discovering a 15-year-old before anyone knows his name. Those are different muscles. Pre-seed and seed aren’t Series A with smaller checks. But calling ourselves specialists isn’t enough. Only the best will survive!
28
6
2
155
10,121
After a year of volunteering with CubbonWalks, I and friend Radha Rangarajan are starting a venture of our own! Slow, unhurried walks all over Bangalore
I've tried meditation, I've tried chanting. I strongly recommend staring at trees
4
17
97
2,000
I've watched a few really good founders raise big seed rounds this year, then struggle to raise their A, even as the business kept making progress. The seed valuation had set a bar they weren't ready to clear yet. And with everyone excited about the term sheet, it was easy to put off what they'd need to show at the next round. One of them had about as strong a resume as you'll see in AI, and a team to match. Sub-$1M ARR would have been a fine A story at a normal seed price. At theirs it wasn't. (For what it's worth, I write both seed and A checks, so I sit on both sides of this.) The top of the seed market is a bit wild right now. Carta's 95th percentile seed valuation was about $72M in Q2 last year. This Q2 it was $200M. Meanwhile the share of seed companies that get to a Series A within two years has roughly halved since 2018. During a raise almost all the attention goes to how much and at what valuation. The question I wish more founders asked is whether the company is actually set up to hit the growth the next round will expect. If you're planning on a 2-3x step-up at the A, here's what that means. A $25M post means pitching a $50-75M A, which a company with real traction can get to. A $100M post means $200-300M, and at that price the A partner is comparing you to the handful of companies growing faster than almost anyone. The bar right now is brutal. In the A conversations I'm in, a $15M seed (usually a $75-100M post today) means $2M+ ARR, growing 5-6x over the last year, with a believable path to another 5x. None of this means raise less. Before you sign, work backward: what will we need to show at the A, and does this money and ~24 months get us there? If it does and the terms are good, take it. If the honest answer is "only if everything goes right", that's worth knowing now rather than in month 20. A big seed buys you runway and a higher bar. Most founders only count the runway.
19
18
8
111
45,648
Arjun retweeted
Seinfeld's reruns have made Jerry Seinfeld and Larry David hundreds of millions of dollars. Jason Alexander, who played George, says he has made less than $200,000 from them. That gap is part of why the show ended. In the video below, Alexander explains why George, Elaine and Kramer stopped wanting more seasons. In 1997, Seinfeld was the biggest comedy on TV. NBC offered Jerry $5 million an episode, about $110 million, for a tenth season. He said no. Every year before the Christmas break, Jerry asked his three co-stars if they wanted to keep going. In season 9, they all said it was done. Alexander, Julia Louis-Dreyfus and Michael Richards were not partners in syndication. The reruns would pay Jerry and Larry for life. Not them. "Seinfeld wasn't going to be the annuity for us that it was going to be for Jerry and Larry," Alexander says. Every new season tied them tighter to one character. "We were going to contribute to our own eventual demise as actors." The case for Jerry: he and Larry created the show and owned it. The cast signed their deals and were paid well, reportedly $600,000 an episode by the end. Before the final taping, the four of them held hands backstage like every week. They called it the circle of power. Jerry said: "For the rest of our lives, when anyone thinks of one of us, they will think of all four of us." Alexander says they walked out looking like they'd been hit by a truck. So should Jerry have shared the reruns with George, Elaine and Kramer?
1,440
422
97
8,596
3,012,100
NEW: In 2021, Apollo acquired a massive internet business for ~$5B. Just 5 years later, it's become *one of the fastest-returning deals in the firm's history.* 700M monthly users. Billions in revenue. And an enormous distribution advantage that would be nearly impossible to replicate today. Apollo's Reed Rayman recruited Jim Lanzone (@jlanzone) to lead the turnaround. The company? @Yahoo. I sat down with CEO Jim Lanzone, one of the internet industry's most accomplished turnaround executives, to go inside @apolloglobal's PE M&A playbook for Yahoo, the economics of the acquisition, & why this may be one of the most underrated assets in tech. The numbers: › ~$5B acquisition › 700M monthly users, including 100M+ each across Yahoo Finance & Sports › 75% direct traffic, with ~75% of daily users logged in › Hundreds of millions in annual ad-tech losses addressed through restructuring › Major divestitures including AOL, TechCrunch & Edgecast › One of Apollo's fastest-returning deals, with Jim saying they're now "playing with house money" › Newer search companies valued at 6X Yahoo despite having a fraction of its users, revenue & profitability But the most interesting part of this deal is the operator. Before Yahoo, Jim helped drive a 50X stock increase at Ask Jeeves, grew CBS Interactive from 70M to 220M users, and led Tinder. And unlike the traditional PE playbook of aggressive cost extraction, PE micromanagement, Apollo backed an experienced product executive to restructure the business, rebuild its leadership, & reinvest in growth. Now Yahoo is moving from turnaround to comeback, with an entirely rebuilt product ecosystem, its own AI search engine through Yahoo Scout, and a potential path back to the public markets. We get into what it's really like operating under Apollo, the leadership decisions behind the turnaround, the value of internet distribution at scale, and why some startups with less than 0.1% of Yahoo's users command higher valuations. 𝐓𝐈𝐌𝐄𝐒𝐓𝐀𝐌𝐏𝐒 (00:00) Jim Lanzone, CEO of Yahoo (01:33) How Apollo bought Yahoo for $4.8B (04:16) Taking over a company in the middle of COVID (07:22) Is private equity really the villain? (12:42) The mistake that handed Google the internet (16:09) Where Yahoo's 700M monthly users come from (17:07) Why Yahoo sold AOL & TechCrunch (21:21) "You can't skip levels of the video game" (27:58) Why people still trust Yahoo in the AI era (30:26) How Yahoo Scout competes with ChatGPT & Perplexity (33:48) Saying no to the AI gold rush? (37:31) From turnaround to comeback (39:42) One of the fastest paybacks in Apollo history (42:50) The biggest mistake companies make at scale (44:21) Silicon Valley startups are now worth more than Yahoo with 0.1% of its users (46:25) Why Yahoo is ready for the next crash (48:57) Barry Diller, Tinder & the tweet that predicted Yahoo (54:36) Is Yahoo finally back?
24
30
20
245
116,345
Larry David is one of America’s unlikeliest icons, and one of history’s purest founders. In our latest profile, Correspondent-at-Large @blakejharrisNYC—who spent six years talking to Larry for his new book—explains what makes Larry so special, and why it took him so long to break through. Larry was a mediocre student with a middling social life. His first two jobs—selling bras and driving cabs—ended quickly. At 25, he called his mother from a hotel room: “Ma, nothing good is ever gonna happen to me.” She urged him to become a mailman. Soon after, he found what he thought would be his calling: stand-up comedy. His material was funny, but he rarely finished a set. If somebody in the audience looked at their watch, or didn’t laugh when he thought they should, Larry stormed off. 14 years later, aged 39, he got a break. He was asked to write his first sitcom script for a big new Showtime series. Only an eighth of what he wrote survived the edit, but the episode was still his. He was broke, and the writing credit could have sparked his career. But Larry refused to put his name on it. Even with Seinfeld, Larry nearly hit self-destruct. The pilot performed worse than almost any other show NBC had ever tested. Still, the network ordered four episodes, one of the smallest orders in TV history. Larry barely made it through them. When the studio installed a showrunner to oversee the scripts, Larry endured the man’s notes, then said “NO. I’m not doing one thing,” and walked out. In the summer of 1991, with the show finally starting to work, NBC wanted Jerry and Elaine to get married and have a baby. Larry quit in the parking lot and wished everyone good luck. Jerry stood with Larry, and NBC caved. Larry’s friend and comedian Bill Scheft put it this way: “He doesn’t [act this way now] because he has fuck-you money. It’s the opposite. He has the fuck-you money because he’s always acted this way.” Read the full profile by Blake, author of Emperor of Nothing: The Making of Larry David. colossus.com/article/many-fa…
11
62
30
591
284,628